Should gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy?
Sinha, Rajiv
Should gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy? [electronic resource] - Archives of disease in childhood May 2008 - 444-5 p. digital
Publication Type: Journal Article; Review
1468-2044
10.1136/adc.2007.131334 doi
Acute Kidney Injury--complications
Adolescent
Antineoplastic Agents, Alkylating--adverse effects
Cyclophosphamide--adverse effects
Female
Gonadotropin-Releasing Hormone--therapeutic use
Humans
Lupus Erythematosus, Systemic--drug therapy
Primary Ovarian Insufficiency--chemically induced
Should gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy? [electronic resource] - Archives of disease in childhood May 2008 - 444-5 p. digital
Publication Type: Journal Article; Review
1468-2044
10.1136/adc.2007.131334 doi
Acute Kidney Injury--complications
Adolescent
Antineoplastic Agents, Alkylating--adverse effects
Cyclophosphamide--adverse effects
Female
Gonadotropin-Releasing Hormone--therapeutic use
Humans
Lupus Erythematosus, Systemic--drug therapy
Primary Ovarian Insufficiency--chemically induced